The MTHFR 677 C→T genotype modifies the relation of folate intake and status with plasma homocysteine in middle-aged and elderly people

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 30, Issue 3, 2005, Pages 208-217

  Ozturk H ^a   Durga, Jane ^a,b   Van De Rest, O ^a,b   Verhoef, P ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

Elderly; Folate intake; Methylenetetrahydrofolate reductase; Red blood cell folate; Serum folate; Total homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; PLACEBO;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENOTYPE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; RANDOMIZED CONTROLLED TRIAL;

EID: 23844521294     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Clarke, Collins, Lewington, Alfthan, Brattström, Hofman, Stehouwer, Luft, Loehrer, Nygard, Kromhout, Whinicup Linksted (Homocysteine Studies Collaboration). Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002; 288: 2015-2022.
2. Bree A de, Verschuren WMM, Kromhout D, Kluijtmans LAJ, Blom HJ. Homocysteine determinants and the evidence to what extent determine the risk of coronary heart disease. Pharmacol Rev 2002; 54: 599-618.
3. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72: 324-332.
4. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
5. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Scheuten E and the MTHFR Studies Collaboration Group. MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease; a meta-analysis. JAMA 2002; 288: 2015-2042.
6. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelial randomisation. Lancet 2004; 365: 224-232.
7. Stern LL, Shane B, Bagley PJ, Nadeau M, Shih V, Selhub J. Combined Marginal Folate and Riboflavin Status Affect Homocysteine Methylation in Cultered Immortalized Lymphocytes from persons Homozygous for the MTHFR C677T mutation. Am Soc Nutrit Sciences 2003; 133: 2716-2720.
8. Bree A de, Verschuren WMM, Blom HJ, Kromhout D. Association between B- vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 year. Am Soc Clin Nutr 2001; 73: 1027-1033.
9. Woodside JV, Yarnell JWG, McMaster D, Young IS, Harmon DL, Mc Crum EE, Patterson CC, Gey KF, Whitehead AS, Evans A. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr 1998; 67: 858-866.
10. Ashfield-Watt P, Pullin CH, Whitting JM, Clark ZE, Moat SJ, Newcombe RG, Burr ML, Lewis MJ, Powers HJ, McDowell IFW. Methyletetrahydrofolate reductase 677C→T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplementation: a randomized controlled trial. Am J Clin Nutr 2002; 76: 180-186.
11. Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlman AM, Nau H, Berthold HK, Pietrzik K. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5- methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 2002; 75: 275-282.
12. Guinotte CL, Burns MG, Axume JA, Hata H, Urrutia TF, Alamilla A, McCabe D, Singh A, Cogger EA, Caudill MA. Methylenetetrahydrofolate reductase 677→T variant modulates folate status responses to controlled folate intakes in young women. American Society for Nutritional Sciences 2003; 133: 1272-1280.
13. Shelnut KP, Kauwell KPA, Chapman CP, Gregory JS, Maneval DR, Browdy AA, Theriaque DW, Bailey LB. Folate status Response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677→T polymorphism in young women. American Society for Nutritional Sciences 2003; 133: 4107-4111.
14. Hiraoka M, Kato K, Saito Y, Yasuda K, Kagawa Y. Gene-nutrient and gene-gene interactions of controlled folate intake by Japanese women. Biochem Biophys Res Comm 2004; 316: 1210-1216.
15. Liu C-S, Chiang H-C, Chen H-W. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease. Nutrition 2004; 20: 974-978.
16. Brants HAM, Bausch-Goldbohm R.A. Ontwikkeling van een voedselfrequentie- vragenlijst naar de foliumzuurinneming van ouderen (vertrouwelijk) Zeist, TNO Nutrition and Food Research, 2001
17. Zo eet Nederland, 1992. Resultaten van de Voedselconsumptiepeiling 1992. Voorlichtingsbureau voor de Voeding, Den Haag, 1993.
18. Holland B, Welch AA, Unwinn ID, Buss DH, Paul AA, Southgate DAT. McCance and Widdowson's the composition of foods. Cambridge, United Kingdom: Royal Society of Chemistry, 1991.
19. Hulshof KFAM, Heyden LJM van der, Donders-Engelen M. Maten, gewichten en codenummers 1992. TNO Voeding/Wageningen Universiteit. rapportnummer V92.003, Zeist, 1992.
20. Bouman M, Kistemaker C. Probleemdefinities naar de ontwikkeling van een geautomiseerd systeem voor het maken van voedselfrequentie lijsten (vertrouwelijk) TNO Voeding, Rapportnummer V94.676, Zeist, 1994a.
21. Bouman M, Erp-Baart MA van, Brants H, Bausch S, Westenbrink S. Definitie Studie naar de ontwikkeling van een geautomatiseerd systeem voor het maken van voedsel frequentielijsten (vertrouwelijk). TNO Voeding, Rapportnummer V94.677, Zeist, 1994b.
22. Bouman M, Erp-Baart MA van, Brants H, Bausch S. Voedsel Frequentie Expert, de ontwikkeling van een geautomatiseerd systeem voor het maken van voedselfrequentie lijsten (vertrouwelijk) Deel 1- Het functionele ontwerp. TNO Voeding, Rapportnummer V98.721, Zeist, 1998a.
23. Bouman M, Brants HAM. Voedsel frequentie Expert, de ontwikkeling van een geautomatiseerd systeem voor het maken van voedsel frequentielijsten (vertrouwelijk) Deel 2- Het technisch ontwerp. TNO Voeding, Rapportnummer V98.722, Zeist, 1998b.
24. NEVO-tabel. Nederlands Voedingsstoffenbestand 1993. Stichting Nederlands Voedingsstoffenbestand. Voorlichtingsbureau voor de Voeding, Den Haag, 1993
25. Ubbink JB, Hay ward-Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991; 565: 441-446.
26. Ueland PM, Refsum H, Stabler SP, Malinow MR, Anersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-1779.
27. Ubbink JB, Serfontein WJ, Villiers LS de. Stability of pyridoxal-5-phosphate semicarbazone: applications in plasma vitamin B6 analysis and population surveys of vitamin B6 nutritional status. J Chromatogr 1985: 342: 277-284.
28. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
29. Pitkin RM, Allen LH, Bernefield M, Wals P, Green R, Donald-Mc Cormick B, Russell RM, Shane B, Zeisel SH, Rosenberg I. Dietary reference intakes, National Academy press, Washington DC 1998; 207-224.
30. Bree A de, Verschuren WMM, Kromhout D, Kluytmans LAJ, Blom HJ. Homocysteine Determinants and the Evidence to what extent Homocysteine Determines the Risk of Coronary Heart Disease. Am Soc for Pharmacology and Experimental Therapeutics 2002; 54: 599-619.
31. Statistics with confidence 2nd edition, DG Altman, D Machin, TN Bryant, MJ Gardner. British Medical Journal 2003.
32. Intuitive Biostatistics, H Motulsky, Oxford University, 1995.
33. Health Council of the Netherlands. Dietary reference in intakes: vitamin B6, folate and vitamin B12. The Hague: Health Council of the Netherlands, 2003
34. Moat SJ, Ashfield-Wat PAL, Powers HJ, Newcombe RG, McDowell IFW. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clinical Chemistry 2003; 49: 295-302.
35. Harmon DL, Woodside JV, Yarnell JW et al. The common "thermo- labile" variant of mehylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia. QJMed 1996; 89: 571-577.
36. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C667T Mutation of methyleneterahydrofolate reductase is an independent risk determinant of carotid wall thickening. Circulation 1997; 96[suppl I]: 651-655.
37. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formalyted tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 1998; 95: 13217-13220.
38. Molloy AM, Mills JL, Kirke PN, Whitehead AS, Weir DG, Scott JM. Whole-blood Folate Values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem 1998; 44: 186-188.
39. Oort FV van, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB, Verhoef P. Folic acid and reduction of plasma homocysteine concentration in older adults: a dose responding study. Am J Clin Nutr 2003; 77: 1318-1323.
40. Klerk M. Homocysteine and coronary heart disease; the role of polymorphic genes and hemostasis. PhD thesis Wageningen University, 2002.